3652 results for «280»
3652 results
Treatment of atherosclerotic vasospastic plaque in proximal left anterior descending and left main
17 May 2022 – From EuroPCR 2022
Discover the case of a 57 year-old male patient presenting with chest pain, ECG-ST segment depression in all precordial leads and elevated HS troponins. He already suffered from this event 2 years ago (treated conservatively). Angiogram reveals a vasospastic atherosclerotic plaque in proximal LAD and LM....
New insights in coronary artery disease and OHCA
17 May 2022 – From EuroPCR 2022
Consult this session to gain insights into coronary artery disease and OHCA: learn about the 4-year clinical outcomes of the RESTORE SVD trial regarding the Restore DCB, the results of the FAVOR III trial comparing QFR-guided vs angiography-guided PCI in patients with MVD, and more!
Transcatheter solutions in complex valvular or structural scenarios - Part 1
17 May 2022 – From EuroPCR 2022
Watch these videos dedicated to transcatheter solutions in complex valvular or structural scenarios to discover a selection of challenging cases: downward dislocation of a TAVI valve into the left ventricle, failed aortic valve after ROSS procedure, and much more!
The Future of TAVI
19 May 2022 – From EuroPCR 2022
Consut this session if you want to appraise the originality of the TAVI concept, to learn the feasibility of minimalist procedure and fast track patient pathway and to understand the expansion of indications and the future of TAVI.
Treatment of small vessel disease - To stent or not to stent?
07 Oct 2022 – From AICT-AsiaPCR 2022
Consult this session if you want to learn the tips and tricks to perform a small vessel disease intervention and to discuss the pros and cons of treating small vessel disease with DCB and/or DES.
Advances in left main bifurcation PCI and renal denervation
06 Oct 2022 – From AICT-ASIAPCR 2022
Discover more about treatment strategies and recent evidence for left main bifurcation, the latest Malaysian Working Group consensus statement on renal denervation, as well as reviewing patient-centred clinical judgement and individualised treatment plans.
Evolving approaches to planning and guiding of complex PCI with ultra-low contrast
06 Oct 2022 – From AICT-ASIAPCR 2022
In this session, presenters describe how to use IVUS and physiology in the assessment of left anterior descending and/or left circumflex ostium in distal left main disease. Discover in the second part the general principles and clinically validated strategies for ultralow contrast coronary angiography and zero...
Cracking calcium: best practices to integrate intravascular lithotripsy into your calcium management algorithm
07 Oct 2022 – From AICT-ASIAPCR 2022
With this session, keep up to date on the evidence, trials and outcome data for intravascular lithotripsy in severely calcified lesions. Learn how to use this technique in real-world patients and understand its role in the treatment algorithm for severely calcified coronary lesions.
Sirolimus coated balloon: expanding the scope of coronary artery disease treatment
07 Oct 2022 – From AICT-ASIAPCR 2022
Consult this session to understand the technology and scientific evidence of the novel sirolimus drug-coated balloon, to learn its utility for PCI in a variety of lesion and patient subsets and to understand the evidence and outcomes in real-world patients.
Coronary sinus reducer for microvascular angina
28 Feb 2020
A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...
A randomised, multicenter, non-inferiority comparison of intravascular lithotripsy and super-high-pressure non-compliant balloons for treatment of calcified and refractory coronary lesions - The VICTORY trial
27 Oct 2025
Mirvat Alasnag provides her take on the VICTORY trial presented by Matthias Bossard at TCT 2025 in San Francisco.
Author
The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction
18 Nov 2024
Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.
Author
